36th Annual New Treatments in Chronic Liver Disease CME Conference

Memo

This conference will review the latest medications and therapies in liver treatment and transplantation. The results of trials and real world data using oral drugs to treat chronic viral hepatitis B and C, non-alcoholic fatty liver diseases, primary biliary cirrhosis, primary sclerosing cholangitis, hepatocellular carcinoma and complications of end-stage liver disease including thrombocytopenia will be reviewed in detail. New Treatments in Chronic Liver Disease is a comprehensive yet concise program for updating physicians on these and other commonly encountered problems in the treatment of liver diseases. Prices:In Person-Physicians (MD, DO, MBBS): USD 350.0,In Person-RN, NP, PA, Other: USD 300.0,In Person-Fellows, Residents, Students: USD 175.0,Virtual-Physicians (MD, DO, MBBS): USD 200.0,Virtual-Non-Physician: USD 125.0,Virtual-Fellows, Residents, Students: USD 100.0Speakers: Paul J. Pockros, MD, FACG, Catherine T. Frenette, MD, FAST, AGAF, Michael B. Charlton, MD, FRCP, Adam Deising, DO, Julio A. Gutierrez, MD, Kris V. Kowdley, MD, FACP, FACG, FASGE, AGAF, FAASLD, Timothy R. Morgan, MD, Mazen, Noureddin, MD, Patrick Northup, MD, Mary E. Rinella, MD, Matthew Skinner, MD, Norah A. Terrault, MD, MPH, John M. Vierling, MD, FACP, FAASLD, AGAF, Florence Wong, MD Date and Time: On Saturday March 12, 2022 at 8:00 am (Sunday March 13, 2022 at 11:30 am) Venue Details: San Diego Mission Bay Resort, 1775 East Mission Bay Drive, San Diego, California, 92109, United States